The Science and Technology Committee holds the third session of its genomics and genome editing inquiry, looking at the challenges and opportunities of genome editing in the UK.
Wednesday 29 March 2017, Committee Room 16, Palace of Westminster
- Professor Waseem Qasim, Professor in Cell & Gene Therapy, Institute of Child Health
- Alastair Kent, Director, Genetic Alliance UK
- Dr Kathy Niakan, Group Leader, The Francis Crick Institute
- Dr Andy Greenfield, Programme Leader, Medical Research Council's Harwell Institute
- Robin Lovell-Badge, Senior Group Leader, The Francis Crick Institute
- James Lawford Davies, Partner, Hempsons
- Philippa Taylor, Head of Public Policy, Christian Medical Fellowship
Purpose of the session
Two panels of experts take part in the session. The first panel looks at the practical challenges of undertaking research into gene editing, and how this translates into NHS treatment while taking account of patient perspectives. The second panel looks in greater detail at the ethical, regulatory and international issues surrounding innovative genome editing techniques.